BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bilici A. Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World J Gastroenterol 2014; 20(31): 10802-10812 [PMID: 25152583 DOI: 10.3748/wjg.v20.i31.10802]
URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10802.htm
Number Citing Articles
1
Rubeshen Pillay Arnachellum, Melanie Cariou, Jean-Baptiste Nousbaum, Julien Jezequel, Jean Yves Le Reste, Michel Robaszkiewicz. Pancreatic Adenocarcinoma in the Finistère Area, France, Between 2002 and 2011 (1002 Cases)Pancreas 2016; 45(7): 953 doi: 10.1097/MPA.0000000000000594
2
Sarang Hong, Ki Byung Song, Dae Wook Hwang, Jae Hoon Lee, Woohyung Lee, Eunsung Jun, Jaewoo Kwon, Yejong Park, Seo Young Park, Naru Kim, Dakyum Shin, Hyeyeon Kim, Minkyu Sung, Yunbeom Ryu, Song Cheol Kim. Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinomaWorld Journal of Gastrointestinal Surgery 2021; 13(11): 1423-1435 doi: 10.4240/wjgs.v13.i11.1423
3
Qingqing Wang, Qichao Ni, Xudong Wang, Huijun Zhu, Zhiwei Wang, Jianfei Huang. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survivalMedical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0372-2
4
Pablo Sala Elarre, Esther Oyaga-Iriarte, Kenneth H. Yu, Vicky Baudin, Leire Arbea Moreno, Omar Carranza, Ana Chopitea Ortega, Mariano Ponz-Sarvise, Luis D. Mejías Sosa, Fernando Rotellar Sastre, Blanca Larrea Leoz, Yohana Iragorri Barberena, Jose C. Subtil Iñigo, Alberto Benito Boíllos, Fernando Pardo, Javier Rodríguez Rodríguez. Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of RelapseCancers 2019; 11(5): 606 doi: 10.3390/cancers11050606
5
Klaus Felix, Ulf Hinz, Sophie Dobiasch, Thilo Hackert, Frank Bergmann, Magnus Neumüller, Simon Gronowitz, Mattias Bergqvist, Oliver Strobel. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic CancerPancreas 2018; 47(1): 72 doi: 10.1097/MPA.0000000000000966
6
Wei Fang Dai, Jaclyn Beca, Helen Guo, Wanrudee Isaranawatchai, Deborah Schwartz, Rohini Naipaul, Jessica Arias, Yao Qiao, Scott Gavura, Ruby Redmond‐Misner, Zahra Ismail, Lisa Barbera, Kelvin Chan. Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer?Cancer Medicine 2020; 9(1): 215 doi: 10.1002/cam4.2704
7
Ricardo P. Martinho, Qingjia Bao, Stefan Markovic, Dina Preise, Keren Sasson, Lilach Agemy, Avigdor Scherz, Lucio Frydman. Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized 13 C MRSI, 1 H diffusivity and 1 H T 1 MRI NMR in Biomedicine 2021; 34(2) doi: 10.1002/nbm.4446
8
Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro, Maria Maddalena Laterza, Alessio Fabozzi, Beatrice Savastano, Angelica Petrillo, Anna Diana, Guido Giordano, Teresa Troiani, Giovanni Conzo, Gennaro Galizia, Fortunato Ciardiello, Michele Orditura. NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practiceBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2671-9
9
Weihong Wang, Chanyoon Park, Eunseok Oh, Youjung Sung, Jusung Lee, Kyu-Hyung Park, Heonjoong Kang. Benzophenone Compounds, from a Marine-Derived Strain of the Fungus Pestalotiopsis neglecta, Inhibit Proliferation of Pancreatic Cancer Cells by Targeting the MEK/ERK PathwayJournal of Natural Products 2019; 82(12): 3357 doi: 10.1021/acs.jnatprod.9b00646
10
Raju Kandimalla, Hideo Tomihara, Jasjit K. Banwait, Kensuke Yamamura, Gagandeep Singh, Hideo Baba, Ajay Goel. A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal AdenocarcinomaClinical Cancer Research 2020; 26(14): 3641 doi: 10.1158/1078-0432.CCR-19-4044
11
Joo Kyung Park, Hyemin Kim, Dae-Soon Son, Nayoung K. D. Kim, Young Kyung Sung, Minseob Cho, Chung Lee, Dong Hyo Noh, Se-Hoon Lee, Kyu Taek Lee, Jong Kyun Lee, Kee-Taek Jang, Woong-Yang Park, Kwang Hyuck Lee. Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Using Integrated Clinico-Genomic Data of Endoscopic Ultrasound-Guided Fine Needle BiopsyCancers 2021; 13(11): 2791 doi: 10.3390/cancers13112791
12
Dimitrios Schizas, Alkmini Koumpoura, Meropi Galari, Panagiota Economopoulou, Michail Vailas, Maria Sotiropoulou, Dimitrios Dimitroulis, Ioannis Maroulis, Evangelos Felekouras. A personalized approach to pancreatic ductal adenocarcinoma and its application in surgical practicePersonalized Medicine 2021; 18(6): 613 doi: 10.2217/pme-2021-0031
13
Christof Kaltenmeier, Ibrahim Nassour, Richard S. Hoehn, Sidrah Khan, Alison Althans, David A. Geller, Alessandro Paniccia, Amer Zureikat, Samer Tohme. Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort StudyJournal of Gastrointestinal Surgery 2021; 25(9): 2307 doi: 10.1007/s11605-020-04870-6
14
Haiqun Xing, Zhixin Hao, Wenjia Zhu, Dehui Sun, Jie Ding, Hui Zhang, Yu Liu, Li Huo. Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomicsEJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00760-3
15
Shinichi Ikuta, Tsukasa Aihara, Naoki Yamanaka. Preoperative C‐reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinomaAsia-Pacific Journal of Clinical Oncology 2019; 15(5) doi: 10.1111/ajco.13123
16
Hui Zhao, Qingqing Wang, Xudong Wang, Huijun Zhu, Shu Zhang, Wei Wang, Zhiwei Wang, Jianfei Huang. Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic CancerPancreas 2016; 45(2): 204 doi: 10.1097/MPA.0000000000000453
17
Hye Jin Kim, Mi-Suk Park, Jin Yong Lee, Kyunghwa Han, Yong Eun Chung, Jin-Young Choi, Myeong-Jin Kim, Chang Moo Kang. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal AdenocarcinomaCancer Research and Treatment 2019; 51(1): 24 doi: 10.4143/crt.2017.404
18
Zibo Meng, Mingsi Cao, Yushun Zhang, Zhiqiang Liu, Shihong Wu, Heshui Wu. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysisBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0975-3
19
Hongxing Gui, Christopher P. Julien, Suehyb G. Alkhatib, Michael A. Husson. An indolent pancreatic ductal adenocarcinoma with psammoma bodies and a coincidental neuroendocrine tumorHuman Pathology: Case Reports 2019; 16: 100286 doi: 10.1016/j.ehpc.2019.01.005
20
Angus G Dalgleish, Justin Stebbing, Douglas JA Adamson, Seema Safia Arif, Paolo Bidoli, David Chang, Sue Cheeseman, Robert Diaz-Beveridge, Carlos Fernandez-Martos, Rob Glynne-Jones, Cristina Granetto, Bartomeu Massuti, Karen McAdam, Raymond McDermott, Andrés J Muñoz Martín, Demetris Papamichael, Roberto Pazo-Cid, Jose M Vieitez, Alberto Zaniboni, Kevin J Carroll, Shama Wagle, Andrew Gaya, Satvinder S Mudan. Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerBritish Journal of Cancer 2016; 115(7): 789 doi: 10.1038/bjc.2016.271
21
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Zhiyong Liang, Weixun Zhou, Lei You, Junchao Guo. Clinicopathological and prognostic significance of ubiquitin‐specific peptidase 15 and its relationship with transforming growth factor‐β receptors in patients with pancreatic ductal adenocarcinomaJournal of Gastroenterology and Hepatology 2021; 36(2): 507 doi: 10.1111/jgh.15244
22
Huaqiang Ouyang, Weidong Ma, Fang Liu, Zhensong Yue, Minghui Fang, Manman Quan, Zhanyu Pan. Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative carePancreatology 2017; 17(5): 773 doi: 10.1016/j.pan.2017.07.002
23
Zev A. Wainberg, Kynan Feeney, Myung Ah Lee, Andrés Muñoz, Antonio Cubillo Gracián, Sara Lonardi, Baek-Yeol Ryoo, Annie Hung, Yong Lin, Johanna Bendell, J. Randolph Hecht. Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimensBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07110-x
24
Cameron J. Herting, Isaac Karpovsky, Gregory B. Lesinski. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directionsCancer and Metastasis Reviews 2021; 40(3): 675 doi: 10.1007/s10555-021-09988-w
25
Mahdi Sheikh, Sahar Masoudi, Razieh Bakhshandeh, Alireza Moayyedkazemi, Farhad Zamani, Sepideh Nikfam, Masoumeh Mansouri, Neda Ghamarzad Shishavan, Saman Nikeghbalian, Paul Brennan, Reza Malekzadeh, Akram Pourshams, Ulrich Wellner. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective studyPLOS ONE 2020; 15(12): e0243511 doi: 10.1371/journal.pone.0243511
26
Moon Hyung Choi, Young Joon Lee, Seung Bae Yoon, Joon-Il Choi, Seung Eun Jung, Sung Eun Rha. MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcomeAbdominal Radiology 2019; 44(1): 122 doi: 10.1007/s00261-018-1681-2
27
David Goldstein, Daniel D. Von Hoff, E. Gabriela Chiorean, Michele Reni, Josep Tabernero, Ramesh K. Ramanathan, Marc Botteman, Abdalla Aly, Sandra Margunato-Debay, Brian Lu, Chrystal U. Louis, Desmond McGovern, Chee Khoon Lee. Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic CancerPancreas 2020; 49(6): 744 doi: 10.1097/MPA.0000000000001563
28
Fengming Ji, Qiang Kang, Lianmin Wang, Lixin Liu, Yang Ke, Ya Zhu, Naiqiang Zhang, Shifeng Xiong, Yuehua Li, Hao Zou. Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patientsMedicine 2020; 99(43): e22827 doi: 10.1097/MD.0000000000022827
29
Yuki Hashimoto, Mitsuaki Ishida, Hironori Ryota, Tomohisa Yamamoto, Hisashi Kosaka, Satoshi Hirooka, So Yamaki, Masaya Kotsuka, Yoichi Matsui, Hiroaki Yanagimoto, Koji Tsuta, Sohei Satoi. Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohistochemical analysisPancreatology 2019; 19(3): 443 doi: 10.1016/j.pan.2019.03.001
30
Ambica Parmar, Jorge Chaves-Porras, Ronak Saluja, Kaitlyn Perry, Amanda P. Rahmadian, Seanthel Delos Santos, Yoo-Joung Ko, Scott Berry, Mark Doherty, Kelvin K.W. Chan. Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysisCritical Reviews in Oncology/Hematology 2020; 145: 102817 doi: 10.1016/j.critrevonc.2019.102817
31
Charlotte Maulat, Cindy Canivet, Célia Touraine, Sophie Gourgou, Bertrand Napoleon, Laurent Palazzo, Nicolas Flori, Guillaume Piessen, Pierre Guibert, Stéphanie Truant, Eric Assenat, Louis Buscail, Barbara Bournet, Fabrice Muscari. A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP ScoreCancers 2020; 12(4): 783 doi: 10.3390/cancers12040783
32
Ramadevi Subramani, Elizabeth Gonzalez, Arunkumar Arumugam, Sushmita Nandy, Viviana Gonzalez, Joshua Medel, Fernando Camacho, Andrew Ortega, Sandrine Bonkoungou, Mahesh Narayan, Alok kumar Dwivedi, Rajkumar Lakshmanaswamy. Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transitionScientific Reports 2016; 6(1) doi: 10.1038/srep19819
33
A.S. Guerard, A. Ayav, H. Busby, M. Lafitte, H. Rousseau, V. Laurent. Early liver metastases in resectable periampullary cancer: Incidence and risk factorsEuropean Journal of Radiology 2017; 93: 265 doi: 10.1016/j.ejrad.2017.06.005
34
Sunnie Kim, James E. Signorovitch, Hongbo Yang, Oscar Patterson-Lomba, Cheryl Q. Xiang, Brian Ung, Monika Parisi, John L. Marshall. Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United StatesAdvances in Therapy 2018; 35(10): 1564 doi: 10.1007/s12325-018-0784-z
35
J. Ventriglia, A. Petrillo, M. Huerta Alváro, M. M. Laterza, B. Savastano, V. Gambardella, G. Tirino, L. Pompella, A. Diana, F. Iovino, T. Troiani, E. Martinelli, F. Morgillo, M. Orditura, A. Cervantes, F. Ciardiello, F. De Vita. Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score AnalysisGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/2373868
36
Jiayu Liu, Nannan Song, Yibing Huang, Yuxin Chen. Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathwayScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33229-w
37
Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md Imtaiyaz Hassan. Investigating the role of transcription factors of pancreas development in pancreatic cancerPancreatology 2018; 18(2): 184 doi: 10.1016/j.pan.2017.12.013
38
Ying Zhu, Jianbo Tian, Xiating Peng, Xiaoyang Wang, Nan Yang, Pingting Ying, Haoxue Wang, Bin Li, Yue Li, Ming Zhang, Yimin Cai, Zequn Lu, Siyuan Niu, Yao Li, Rong Zhong, Jiang Chang, Xiaoping Miao. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosisEuropean Journal of Cancer 2021; 151: 94 doi: 10.1016/j.ejca.2021.04.008
39
Charles Tzu-Chi Lee, Jie-Xi Hu, Chin-Mei Liu. Exploring prior diseases associated with pancreatic cancerCurrent Problems in Cancer 2021; 45(5): 100707 doi: 10.1016/j.currproblcancer.2021.100707
40
Hussein H. Khachfe, Joseph R. Habib, Ibrahim Nassour, Salem Al Harthi, Faek R. Jamali. Borderline Resectable and Locally Advanced Pancreatic CancersPancreas 2021; 50(9): 1243 doi: 10.1097/MPA.0000000000001924
41
Chien-shan Cheng, Wei Liu, Liangping Zhou, Wei Tang, Ailing Zhong, Zhiqiang Meng, Lianyu Chen, Zhen Chen. Prognostic Predicting Role of Contrast-Enhanced Computed Tomography for Locally Advanced Pancreatic AdenocarcinomaBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1356264
42
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Weixun Zhou, Junchao Guo. Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancerScandinavian Journal of Gastroenterology 2021; 56(1): 59 doi: 10.1080/00365521.2020.1853806
43
Zengyu Feng, Peng Chen, Kexian Li, Jianyao Lou, Yulian Wu, Tao Li, Chenghong Peng. A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal AdenocarcinomaFrontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.650264
44
Yu-Guang Chen, Hsueh-Hsing Pan, Ming-Shen Dai, Chin Lin, Chieh-Sheng Lu, Sui-Lung Su, Ping-Ying Chang, Tzu-Chuan Huang, Jia-Hong Chen, Yi-Ying Wu, Yeu-Chin Chen, Ching Liang Ho. Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive JaundicesMedicine 2015; 94(31): e1298 doi: 10.1097/MD.0000000000001298
45
Johanna Wennerblom, Pushpa Saksena, Claes Jönsson, Anders Thune. Lymph node 8a as a prognostic marker for poorer prognosis in pancreatic and periampullary carcinomaScandinavian Journal of Gastroenterology 2018; 53(2): 225 doi: 10.1080/00365521.2017.1417474
46
Raju Kandimalla, Tadanobu Shimura, Saurav Mallik, Fuminori Sonohara, Susan Tsai, Douglas B. Evans, Song Cheol Kim, Hideo Baba, Yasuhiro Kodera, Daniel Von Hoff, Xi Chen, Ajay Goel. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal AdenocarcinomaAnnals of Surgery 2022; 275(1): e229 doi: 10.1097/SLA.0000000000003945
47
Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park. Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancerGastrointestinal Endoscopy 2018; 88(6): 926 doi: 10.1016/j.gie.2018.06.024
48
Sari F Alhasan, Beate Haugk, Laura F Ogle, Gary S Beale, Anna Long, Alastair D Burt, Dina Tiniakos, Despina Televantou, Fareeda Coxon, David R Newell, Richard Charnley, Helen L Reeves. Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinomaBritish Journal of Cancer 2016; 115(7): 797 doi: 10.1038/bjc.2016.264
49
W S Tummers, J V Groen, B G Sibinga Mulder, A Farina-Sarasqueta, J Morreau, H Putter, C J van de Velde, A L Vahrmeijer, B A Bonsing, J S Mieog, R J Swijnenburg. Impact of resection margin status on recurrence and survival in pancreatic cancer surgeryBritish Journal of Surgery 2019; 106(8): 1055 doi: 10.1002/bjs.11115
50
Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini. Prognostic and predictive factors in pancreatic cancerOncotarget 2020; 11(10): 924 doi: 10.18632/oncotarget.27518
51
Zarrukh Baig, Nawaf Abu-Omar, Rayyan Khan, Carlos Verdiales, Ryan Frehlick, John Shaw, Fang-Xiang Wu, Yigang Luo. Prognosticating Outcome in Pancreatic Head Cancer With the use of a Machine Learning AlgorithmTechnology in Cancer Research & Treatment 2021; 20: 153303382110507 doi: 10.1177/15330338211050767
52
Louise S. Rasmussen, Mette K. Yilmaz, Ursula G. Falkmer, Laurids Ø. Poulsen, Martin Bøgsted, Heidi S. Christensen, Stig E. Bojesen, Benny V. Jensen, Inna M. Chen, Astrid Z. Johansen, Carsten P. Hansen, Jane P. Hasselby, Niels Holländer, Svend E. Nielsen, Fahimeh Andersen, Jon K. Bjerregaard, Per Pfeiffer, Julia S. Johansen. Response to the letter entitled: Re: Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancerEuropean Journal of Cancer 2021; 158: 248 doi: 10.1016/j.ejca.2021.09.009
53
Martin A. Styner, Elsa D. Angelini, Jayasree Chakraborty, Liana Langdon-Embry, Joanna G. Escalon, Peter J. Allen, Maeve A. Lowery, Eileen M. O'Reilly, Richard K. G. Do, Amber L. Simpson. Texture analysis for survival prediction of pancreatic ductal adenocarcinoma patients with neoadjuvant chemotherapy Medical Imaging 2016: Image Processing 2016; 9784: 97841W doi: 10.1117/12.2214470
54
Wenzhe Si, Xujun Liu, Rui Wei, Yuan Zhang, Yang Zhao, Liyan Cui, Tianpei Hong. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicityCell Death & Disease 2019; 10(3) doi: 10.1038/s41419-019-1424-5
55
Federico Armando, Adnan Fayyad, Stefanie Arms, Yvonne Barthel, Dirk Schaudien, Karl Rohn, Matteo Gambini, Mara Sophie Lombardo, Andreas Beineke, Wolfgang Baumgärtner, Christina Puff. Intratumoral Canine Distemper Virus Infection Inhibits Tumor Growth by Modulation of the Tumor Microenvironment in a Murine Xenograft Model of Canine Histiocytic SarcomaInternational Journal of Molecular Sciences 2021; 22(7): 3578 doi: 10.3390/ijms22073578
56
Jayasree Chakraborty, Liana Langdon-Embry, Kristen M. Cunanan, Joanna G. Escalon, Peter J. Allen, Maeve A. Lowery, Eileen M. O’Reilly, Mithat Gönen, Richard G. Do, Amber L. Simpson, Surinder K. Batra. Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patientsPLOS ONE 2017; 12(12): e0188022 doi: 10.1371/journal.pone.0188022
57
Shuichi Ota, Mamiko Miyashita, Yuka Yamagishi, Masahiro Ogasawara. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapyHuman Vaccines & Immunotherapeutics 2021; : 1 doi: 10.1080/21645515.2021.2003645
58
Yu-Jen Chen, Ming-Chih Hou, Tsung-Chieh Yang, Pei-Chang Lee, Yee Chao, Chung-Pin Li, Yi-Hsiang Huang, Fa-Yauh Lee. The clinical significance of esophagogastric varices in patients with advanced pancreatic cancerJournal of the Chinese Medical Association 2021; 84(10): 917 doi: 10.1097/JCMA.0000000000000609
59
Xiaoyi Huang, Xiaosong Zhi, Yisha Gao, Na Ta, Hui Jiang, Jianming Zheng. LncRNAs in pancreatic cancerOncotarget 2016; 7(35): 57379 doi: 10.18632/oncotarget.10545
60
Chenlei Wen, XiaXing Deng, Dandan Ren, Xue Song, Hao Chen, Jiancheng Wang, Jiabin Jin, Dongfeng Cheng, Zhiwei Xu, Jun Zhang, Junjie Xie, Wenjing Qi, Jiangning Gu, Chenghong Peng, Dan Chen, Shi Chen, Baiyong Shen, Qian Zhan. Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinomaCancer Medicine 2020; 9(20): 7626 doi: 10.1002/cam4.3425
61
Tyler MacNeil, Ioannis A. Vathiotis, Saba Shafi, Thazin Nwe Aung, Jon Zugazagoitia, Aaron M. Gruver, Kyla Driscoll, David L. Rimm. Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic CancerCancers 2021; 13(21): 5501 doi: 10.3390/cancers13215501
62
Tomotaka Kato, Daisuke Ban, Ukihide Tateishi, Toshiro Ogura, Kosuke Ogawa, Hiroaki Ono, Yusuke Mitsunori, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Reticular pattern around superior mesenteric artery in computed tomography imaging predicting poor prognosis of pancreatic head cancerJournal of Hepato-Biliary-Pancreatic Sciences 2020; 27(3): 114 doi: 10.1002/jhbp.700
63
Lingdi Yin, Linmei Xiao, Yong Gao, Guangfu Wang, Hao Gao, Yunpeng Peng, Xiaole Zhu, Jishu Wei, Yi Miao, Kuirong Jiang, Zipeng Lu. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancerMedical Oncology 2020; 37(5) doi: 10.1007/s12032-020-01370-0
64
Dongjun Dai, Yanmei Wang, Xinyang Hu, Hongchuan Jin, Xian Wang. Prognostic analysis of very early onset pancreatic cancer: a population-based analysisPeerJ 2020; 8: e8412 doi: 10.7717/peerj.8412
65
Shengnan Li, Gengpu Zhang, Xin Li, Xiaojie Li, XiaoBing Chen, Yu Xu, He Ren. Role of the preoperative circulating tumor DNA KRAS mutation in patients with resectable pancreatic cancerPharmacogenomics 2021; 22(11): 657 doi: 10.2217/pgs-2020-0183
66
Jae Uk Chong, Sung Hyun Kim, Ho Kyoung Hwang, Chang Moo Kang, Woo Jung Lee. Yonsei criteria: a clinical reflection of stage I left-sided pancreatic cancerOncotarget 2017; 8(67): 110830 doi: 10.18632/oncotarget.22734
67
Jiangning Gu, Wei Xu, Chenghong Peng, Youwei Zhu, Di Wang, Xuelong Wang, Ying Li, Gang Wei, Zhiqiang Zhang, Yiming Zhong, Shulin Zhao, Minmin Shi, Dongfeng Cheng, Xiayang Ying, Jiabin Jin, Hao Chen. Perineural invasion is related to p38 mitogen‐activated protein kinase pathway activation and promotes tumor growth and chemoresistance in pancreatic cancerJournal of Cellular Biochemistry 2019; 120(7): 11775 doi: 10.1002/jcb.28457
68
Cosimo Sperti, Alberto Friziero, Simone Serafini, Sergio Bissoli, Alberto Ponzoni, Andrea Grego, Emanuele Grego, Lucia Moletta. Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic CancerJournal of Clinical Medicine 2020; 9(7): 2169 doi: 10.3390/jcm9072169